Gilchrist & Soames takes action following FDA investigation

Published: 30-Mar-2016

Two shampoos and two shower gels were found to contain Pseudomonas aeruginosa

You need to be a subscriber to read this article.
Click here to find out more.

Bathroom and body care products manufacturer Gilchrist & Soames has spoken to Cosmetics Business about the action it has taken concerning the issues raised in a warning letter it received this month from the FDA.

The letter, dated 16 March, was sent to the President and CEO of Gilchrist & Soames, Kathie De Voe, in the US after investigators found “significant microbial contamination” in four of its bathroom products during an inspection during autumn 2015.

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Cosmetics Business.

Subscribe now Already a subscriber? Sign in here.

You may also like